Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04191135 |
|---|---|
| Brief Title: | Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009) |
| First Submitted : | December 5, 2019 |
| First Submitted that Met QC Criteria : | December 5, 2019 |
| First Posted : | December 9, 2019 |
| Last Update Submitted that Met QC Criteria : | June 3, 2021 |
| Last Update Posted : | June 4, 2021 |